Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DASATINIB Cause Systemic inflammatory response syndrome? 14 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Systemic inflammatory response syndrome have been filed in association with DASATINIB (dasatinib). This represents 0.1% of all adverse event reports for DASATINIB.

14
Reports of Systemic inflammatory response syndrome with DASATINIB
0.1%
of all DASATINIB reports
11
Deaths
5
Hospitalizations

How Dangerous Is Systemic inflammatory response syndrome From DASATINIB?

Of the 14 reports, 11 (78.6%) resulted in death, 5 (35.7%) required hospitalization.

Is Systemic inflammatory response syndrome Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DASATINIB. However, 14 reports have been filed with the FAERS database.

What Other Side Effects Does DASATINIB Cause?

Pleural effusion (2,424) Fatigue (2,173) Death (1,741) Nausea (1,740) Diarrhoea (1,728) Headache (1,625) Adverse event (1,382) Rash (1,300) Drug ineffective (1,271) Hospitalisation (1,181)

What Other Drugs Cause Systemic inflammatory response syndrome?

DOXORUBICIN (161) METHOTREXATE (158) CYCLOPHOSPHAMIDE (153) CYTARABINE (153) METHYLPREDNISOLONE (117) ADALIMUMAB (107) RITUXIMAB (106) PREDNISOLONE (99) VINCRISTINE (97) MYCOPHENOLATE MOFETIL (95)

Which DASATINIB Alternatives Have Lower Systemic inflammatory response syndrome Risk?

DASATINIB vs DATOPOTAMAB DERUXTECAN-DLNK DASATINIB vs DAUNORUBICIN DASATINIB vs DAXIBOTULINUMTOXIN A-LANM DASATINIB vs DAYTRANA DASATINIB vs DECITABINE

Related Pages

DASATINIB Full Profile All Systemic inflammatory response syndrome Reports All Drugs Causing Systemic inflammatory response syndrome DASATINIB Demographics